Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stephen L Hauser

Showing results (111-120 of 322) with videos related to

Pageof 33
Sort By:
Journal of Neuroinflammation|March 9, 2018
Aberrant STAT phosphorylation signaling in peripheral blood mononuclear cells from multiple sclerosis patientsEster Canto, Noriko Isobe, Alessandro Didonna, et al.
Annals of Neurology|April 8, 2026
Reply to "Comparative Safety Profiles of Ocrelizumab and Rituximab in Multiple Sclerosis Treatment Using Real-World Evidence"Gabriel Cerono, Bruce A C Cree, Stephen L Hauser, et al.
Annals of Neurology|February 11, 2026
Reply to "Comparative Safety Profiles of Ocrelizumab and Rituximab in Multiple Sclerosis Treatment Using Real-World Evidence"Gabriel Cerono, Bruce A C Cree, Stephen L Hauser, et al.
Annals of Neurology|September 8, 2025
Comparative Safety Profiles of Ocrelizumab and Rituximab in Multiple Sclerosis Treatment Using Real-World EvidenceGabriel Cerono, Bruce A C Cree, Stephen L Hauser, et al.
Brain : a Journal of Neurology|April 23, 2010
Ocular pathology in multiple sclerosis: retinal atrophy and inflammation irrespective of disease durationAri J Green, Stephen McQuaid, Stephen L Hauser, et al.
Journal of Neuroimmunology|September 1, 2005
Mapping gene activity in complex disorders: Integration of expression and genomic scans for multiple sclerosisGuy Haskin Fernald, Ru-Fang Yeh, Stephen L Hauser, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|April 25, 2020
Contribution of normal aging to brain atrophy in MSChristina J Azevedo, Steven Y Cen, Amir Jaberzadeh, et al.
European Journal of Immunology|July 20, 2004
Frontline: Epitope recognition on the myelin/oligodendrocyte glycoprotein differentially influences disease phenotype and antibody effector functions in autoimmune demyelinationHans-Christian von Büdingen, Stephen L Hauser, Jean-Christophe Ouallet, et al.
The Journal of Allergy and Clinical Immunology|August 9, 2005
Antibody responses against galactocerebroside are potential stage-specific biomarkers in multiple sclerosisTil Menge, Patrice H Lalive, Hans-Christian von Büdingen, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 13, 2002
Molecular characterization of antibody specificities against myelin/oligodendrocyte glycoprotein in autoimmune demyelinationHans-Christian von Büdingen, Stephen L Hauser, Antje Fuhrmann, et al.
Pageof 33

Showing results (111-120 of 322) with videos related to

Sort By:
Pageof 33
Journal of Neuroinflammation|March 9, 2018
Aberrant STAT phosphorylation signaling in peripheral blood mononuclear cells from multiple sclerosis patientsEster Canto, Noriko Isobe, Alessandro Didonna, et al.
Annals of Neurology|April 8, 2026
Reply to "Comparative Safety Profiles of Ocrelizumab and Rituximab in Multiple Sclerosis Treatment Using Real-World Evidence"Gabriel Cerono, Bruce A C Cree, Stephen L Hauser, et al.
Annals of Neurology|February 11, 2026
Reply to "Comparative Safety Profiles of Ocrelizumab and Rituximab in Multiple Sclerosis Treatment Using Real-World Evidence"Gabriel Cerono, Bruce A C Cree, Stephen L Hauser, et al.
Annals of Neurology|September 8, 2025
Comparative Safety Profiles of Ocrelizumab and Rituximab in Multiple Sclerosis Treatment Using Real-World EvidenceGabriel Cerono, Bruce A C Cree, Stephen L Hauser, et al.
Brain : a Journal of Neurology|April 23, 2010
Ocular pathology in multiple sclerosis: retinal atrophy and inflammation irrespective of disease durationAri J Green, Stephen McQuaid, Stephen L Hauser, et al.
Journal of Neuroimmunology|September 1, 2005
Mapping gene activity in complex disorders: Integration of expression and genomic scans for multiple sclerosisGuy Haskin Fernald, Ru-Fang Yeh, Stephen L Hauser, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|April 25, 2020
Contribution of normal aging to brain atrophy in MSChristina J Azevedo, Steven Y Cen, Amir Jaberzadeh, et al.
European Journal of Immunology|July 20, 2004
Frontline: Epitope recognition on the myelin/oligodendrocyte glycoprotein differentially influences disease phenotype and antibody effector functions in autoimmune demyelinationHans-Christian von Büdingen, Stephen L Hauser, Jean-Christophe Ouallet, et al.
The Journal of Allergy and Clinical Immunology|August 9, 2005
Antibody responses against galactocerebroside are potential stage-specific biomarkers in multiple sclerosisTil Menge, Patrice H Lalive, Hans-Christian von Büdingen, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 13, 2002
Molecular characterization of antibody specificities against myelin/oligodendrocyte glycoprotein in autoimmune demyelinationHans-Christian von Büdingen, Stephen L Hauser, Antje Fuhrmann, et al.
Pageof 33